These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 35434003)

  • 1. CD8
    Zhang Y; Li L; Zheng W; Zhang L; Yao N
    Ann Transl Med; 2022 Mar; 10(6):273. PubMed ID: 35434003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
    Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
    Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
    Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
    Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 6. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC.
    Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q
    BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of a novel signature based on cell-cell communication in head and neck squamous cell carcinoma by integrated analysis of single-cell transcriptome and bulk RNA-sequencing.
    Wang J; Sun HC; Cao C; Hu JD; Qian J; Jiang T; Jiang WB; Zhou S; Qiu XW; Wang HL
    Front Oncol; 2023; 13():1136729. PubMed ID: 37213285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLA2 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.
    Wu Z; You C; Zhu Z; Wu W; Cao J; Xie Q; Deng C; Huang X; Hu S
    Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):427-440. PubMed ID: 37688682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance.
    Han Y; Shi Y; Chen B; Wang J; Liu Y; Sheng S; Fu Z; Shen C; Wang X; Yin S; Li H
    Front Immunol; 2022; 13():961695. PubMed ID: 36389709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance and immune escape implication of tumor-infiltrating neutrophil plasticity in human head and neck squamous cell carcinoma.
    Zhu X; Heng Y; Zhang D; Tang D; Zhou J; Lin H; Ma J; Ding X; Tao L; Lu L
    Hum Cell; 2024 May; 37(3):714-728. PubMed ID: 38358636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
    Chen F; Gong X; Xia M; Yu F; Wu J; Yu C; Li J
    Front Oncol; 2022; 12():857994. PubMed ID: 35619896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiomics data analyses to identify SLC25A17 as a novel biomarker to predict the prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Shi Y; Huang J; Hu Y; Shen Y
    BMC Bioinformatics; 2023 Jun; 24(1):269. PubMed ID: 37386359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of prognostic biomarkers in head and neck squamous cell carcinoma microenvironment from TCGA database.
    Li Y; Bi J; Pi G; He H; Li Y; Han G
    Ann Transl Med; 2023 Feb; 11(4):163. PubMed ID: 36923087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.
    Chen L; Cai Z; Lyu K; Cai Z; Lei W
    Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis.
    Chen X; Yan B; Lou H; Shen Z; Tong F; Zhai A; Wei L; Zhang F
    Mol Immunol; 2018 Apr; 96():28-36. PubMed ID: 29477933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PES1 is a biomarker of head and neck squamous cell carcinoma and is associated with the tumor microenvironment.
    He Y; Xiang J; Li Y; Huang W; Gu F; Wang Y; Chen R
    Cancer Med; 2023 Jun; 12(11):12622-12638. PubMed ID: 37076985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Infiltration Characteristics and a Gene Prognostic Signature Associated With the Immune Infiltration in Head and Neck Squamous Cell Carcinoma.
    Zhu C; Wu Q; Yang N; Zheng Z; Zhou F; Zhou Y
    Front Genet; 2022; 13():848841. PubMed ID: 35586567
    [No Abstract]   [Full Text] [Related]  

  • 18. Developing and validating the model of tumor-infiltrating immune cell to predict survival in patients receiving radiation therapy for head and neck squamous cell carcinoma.
    Xu T; Xu M; Xu Y; Cai X; Brenner MJ; Twigg J; Fei Z; Chen C
    Transl Cancer Res; 2024 Jan; 13(1):394-412. PubMed ID: 38410204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRF1 is a prognostic marker and correlated with immune infiltration in head and neck squamous cell carcinoma.
    Fan C; Hu H; Shen Y; Wang Q; Mao Y; Ye B; Xiang M
    Transl Oncol; 2021 Apr; 14(4):101042. PubMed ID: 33618069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.